4//SEC Filing
BioScrip, Inc. 4
Accession 0001127602-16-054409
$OPCHCIK 0001014739operating
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 2:49 PM ET
Size
9.2 KB
Accession
0001127602-16-054409
Insider Transaction Report
Form 4
BioScrip, Inc.BIOS
GOLDING DAVID W
Director
Transactions
- Exercise/Conversion
Common Stock, $.0001 Par Value
2016-05-31+10,000→ 40,000 total - Disposition to Issuer
Common Stock, $.0001 Par Value
2016-05-31$2.70/sh−10,000$27,000→ 30,000 total - Exercise/Conversion
Phantom Stock
2016-05-31−10,000→ 0 total→ Common Stock, $.0001 Par Value (10,000 underlying)
Footnotes (3)
- [F1]Under the terms of the market-based cash award, as publicly filed, each share of "phantom stock" is the economic equivalent of one share of the Issuer's common stock, par value $0.0001 per share ("Common Stock"). Each share of "phantom stock" granted pursuant to the market-based cash award was entitled to a cash payment equal to the fair market value of a share of Common Stock as of the vesting date, which was $2.70 based on the closing market price of the Common Stock on May 31, 2016.
- [F2]The cash settlement of the market-based cash award is reported solely for purposes of Form 4 as the deemed disposition of the market-based cash award and a deemed simultaneous acquisition and disposition of 10,000 shares of Common Stock.
- [F3]The market-based cash award vested on May 31, 2016, the business day immediately preceding the date of the Issuer's 2016 annual meeting of stockholders, because the reporting person served as a director of the Issuer as of such date. If unvested on the vesting date, the market-based cash award would have expired on May 31, 2016.
Documents
Issuer
BioScrip, Inc.
CIK 0001014739
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001014739
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 2:49 PM ET
- Size
- 9.2 KB